| NCT01397149 | Chronic Lymphocytic Leukemia
... more >> Thrombocytopenia Collapse << | Phase 1
Phase 2 | Terminated(Insufficient recrui... more >>tment) Collapse << | - | Austria
... more >> Medizinische Universität Wien, Innere Medizin I, Abt. Hämatologie und Hämastaseologie
Vienna, Austria, 1090
Germany
Universitätsklinikum Köln; Klinik I für Innere Medizin
Cologne, Germany, 50924
Universitätsklinikum Carl Gustav Carus Med. Klinik und Poliklinik I
Dresden, Germany, 01307
Gemeinschaftspraxis für Innere Medizin, Hämatologie und Internistische Onkologie
Erlangen, Germany, 91052
Universitätsklinikum; Klinik für Hämatologie
Essen, Germany, 45147
Klinikum Frankfurt (Oder) Medizinische Klinik I
Frankfurt (Oder), Germany, 15236
Universitätsklinikum Schleswig-Holstein, II. Medizinische Klinik und Poliklinik im Städtischen Krankenhaus
Kiel, Germany, 24116
Onkologische Schwerpunktpraxis Leer-Emden
Leer, Germany, 26789
Städtisches Klinikum München GmbH, Klinikum Schwabing, Klinik für Hämatologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin
München, Germany, 80804
Universitätsklinikum Ulm, Medizinische Klinik III
Ulm, Germany, 89081 Collapse << |
| NCT02201290 | Purpura, Thrombocytopenic, Idi... more >>opathic Collapse << | Phase 3 | Completed | - | Russian Federation
... more >>
Novartis Investigative Site
Krasnodar, Russian Federation, 350007
Novartis Investigative Site
Moscow, Russian Federation, 117997
Novartis Investigative Site
Saint Petersburg, Russian Federation, 198205 Collapse << |
| NCT01940562 | Pediatric Patients Undergoing ... more >>Allogeneic Cord Blood Transplantation. Collapse << | Phase 2 | Unknown | June 2016 | Israel
... more >> Hadassah hospital
Recruiting
Jerusalem, Israel
Contact: Michael Shapira, MD 972-50-7874433
Schneider Children's Medical Center of Israel
Recruiting
Petah Tikva, Israel, 49202
Contact: Jerry Stein, MD 972-50-4057148 jstein@clalit.org.il
Principal Investigator: Jerry Stein, MD Collapse << |
| NCT03515096 | Eltrombopag
H... more >>ematopoietic Stem Cell Transplantation
Thrombocytopenia Collapse << | Phase 3 | Not yet recruiting | June 1, 2021 | - |
| NCT02912208 | Myelodysplastic Syndromes
... more >> Thrombocytopenia Collapse << | Phase 2 | Recruiting | June 2019 | - |
| NCT02928419 | Myelodysplastic Syndromes | Phase 2 | Terminated("the study has been... more >> closed due to a low rate of patient enrollment (2 patients since the start of the trial)") Collapse << | - | - |
| NCT00370331 | Purpura, Thrombocytopaenic, Id... more >>iopathic Collapse << | Phase 3 | Completed | - | - |
| NCT01890746 | Leukaemia, Acute | Phase 2 | Completed | - | - |
| NCT01890746 | - | - | Completed | - | - |
| NCT02446145 | Acute Myeloid Leukemia | Phase 2 | Recruiting | May 2019 | Germany
... more >> Uniklinik RWTH Aachen
Recruiting
Aachen, Germany
Contact: Martina Crysandt, MD
Charite Campus Benjamin Franklin
Not yet recruiting
Berlin, Germany
Contact: Claudia Baldus, Prof.
Klinikum Chemnitz GmbH
Recruiting
Chemnitz, Germany
Contact: Mathias Hänel, MD
Universitätsklinikum Dresden
Recruiting
Dresden, Germany
Contact: Uwe Platzbecker, Prof.
Marienhospital Düsseldorf GmbH
Not yet recruiting
Düsseldorf, Germany
Contact: Aristoteles Giagounidis, MD
Universitätsklinikum Essen
Recruiting
Essen, Germany
Contact: Richard Noppeney, MD
Universitätsklinikum Halle (Saale)
Recruiting
Halle, Germany
Contact: Petra Tschanter, MD
St. Marien-Hospital Hamm
Not yet recruiting
Hamm, Germany
Contact: Heinz A Dürk, MD
Klinikum rechts der Isar der TU München
Not yet recruiting
München, Germany
Contact: Katharina Götze, MD
Klinikum Nürnberg-Nord
Recruiting
Nürnberg, Germany
Contact: Kerstin Schäfer-Eckart, MD
Medizinisches Versorgungszentrum für Blut- und Krebserkrankungen
Recruiting
Potsdam, Germany
Contact: Hartmut Linde, MD
Wissenschaftskontor Nord GmbH & Co KG
Not yet recruiting
Rostock, Germany
Contact: Andreas Lück, MD
Diakonie-Klinikum Schwäbisch Hall gGmbH
Recruiting
Schwäbisch Hall, Germany
Contact: Thomas Geer, MD
Rems-Murr-Klinikum Winnenden
Recruiting
Winnenden, Germany
Contact: Stefani Parmentier, MD
Universitätsklinikum Würzburg
Not yet recruiting
Würzburg, Germany
Contact: Volker Kunzmann, Prof. Collapse << |
| NCT00102739 | Purpura, Thrombocytopaenic, Id... more >>iopathic Collapse << | Phase 2 | Completed | - | - |
| NCT00358540 | Thrombocytopaenia | Phase 1 | Completed | - | United States, California
... more >>
GSK Investigational Site
Santa Monica, California, United States, 90403
United States, Florida
GSK Investigational Site
Miami, Florida, United States, 33136
GSK Investigational Site
Tampa, Florida, United States, 33612
United States, Pennsylvania
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19106
United States, South Carolina
GSK Investigational Site
Greenville, South Carolina, United States, 29605
United States, Texas
GSK Investigational Site
Dallas, Texas, United States, 75246
GSK Investigational Site
Houston, Texas, United States, 77030-4009 Collapse << |
| NCT01636778 | - | - | Completed | - | - |
| NCT00903422 | Myelodysplastic Syndrome | Phase 1 | Completed | - | - |
| NCT00370331 | - | - | Completed | - | - |
| NCT01098487 | Purpura, Thrombocytopaenic, Id... more >>iopathic Collapse << | Phase 4 | Completed | - | - |
| NCT01636778 | Hepatitis C, Chronic | Phase 2 | Completed | - | Japan
... more >> GSK Investigational Site
Aichi, Japan, 467-8602
GSK Investigational Site
Fukui, Japan, 918-8503
GSK Investigational Site
Fukuoka, Japan, 803-8505
GSK Investigational Site
Fukuoka, Japan, 830-0011
GSK Investigational Site
Gunma, Japan, 370-0829
GSK Investigational Site
Hyogo, Japan, 663-8501
GSK Investigational Site
Ibaraki, Japan, 317-0077
GSK Investigational Site
Kagawa, Japan, 760-0017
GSK Investigational Site
Kagawa, Japan, 760-8557
GSK Investigational Site
Kagoshima, Japan, 899-5112
GSK Investigational Site
Kanagawa, Japan, 213-8587
GSK Investigational Site
Nagasaki, Japan, 856-8562
GSK Investigational Site
Oita, Japan, 879-5593
GSK Investigational Site
Osaka, Japan, 540-0006
GSK Investigational Site
Tokyo, Japan, 105-8470
GSK Investigational Site
Wakayama, Japan, 646-8558 Collapse << |
| NCT01098487 | - | - | Completed | - | - |
| NCT00888901 | Idiopathic Thrombocytopenic Pu... more >>rpura Collapse << | Phase 4 | Completed | - | - |
| NCT01481220 | Myelodysplastic Syndrome
... more >> Thrombocytopenia Collapse << | Phase 1 | Completed | - | Sweden
... more >> 4 Locations
Uppsala, Stockholm, Göteborg, Umeå, Sweden Collapse << |
| NCT01147809 | Thrombocytopaenia | Phase 2 | Completed | - | - |
| NCT01443351 | - | - | Recruiting | March 2020 | Denmark
... more >> Copenhagen University Hospital Roskilde
Recruiting
Roskilde, Denmark, 4000
Contact: Hans C Hasselbalch, Prof., MD +45 26223678 hans.hasselbalch@dadlnet.dk
Principal Investigator: Hans C Hasselbalch, Prof., MD Collapse << |
| NCT01328587 | Moderate Aplastic Anemia
... more >> Unilineage Bone Marrow Failure Disorders Collapse << | Phase 2 | Active, not recruiting | March 30, 2025 | United States, Maryland
... more >>
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892 Collapse << |
| NCT02158936 | Thrombocytopaenia | Phase 3 | Terminated | - | - |
| NCT00908037 | Purpura, Thrombocytopaenic, Id... more >>iopathic Collapse << | Phase 2 | Completed | - | - |
| NCT02158936 | - | - | Terminated | - | - |
| NCT01147809 | - | - | Completed | - | - |
| NCT00908037 | - | - | Completed | - | - |
| NCT00110799 | Hepatitis C, Chronic
... more >> Hepatitis C
Thrombocytopenia Collapse << | Phase 2 | Completed | - | - |
| NCT02298075 | - | - | Recruiting | December 2018 | Italy
... more >> S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti
Recruiting
Asti, Italy
Contact: Monia Marchetti
Principal Investigator: Monia Marchetti
Istituto di Ematologia "Lorenzo e A. Seragnoli"
Recruiting
Bologna, Italy
Contact: Nicola Vianelli
Principal Investigator: Nicola Vianelli
Sub-Investigator: Francesca Palandrini
Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
Not yet recruiting
Catania, Italy
Contact: Ugo Consoli
Principal Investigator: Ugo Consoli
Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
Recruiting
Firenze, Italy
Contact: Alberto Bosi
Principal Investigator: Alberto Bosi
Clinica Medica III - Padiglione ex isolamento - Azienda Ospedale Università San Martino
Recruiting
Genova, Italy
Contact: Enrico Balleari
Principal Investigator: Enrico Balleari
ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE
Recruiting
Lecce, Italy
Contact: Nicola Di Renzo
Principal Investigator: Nicola Di Renzo
Sub-Investigator: Margherita Giannoccaro
Azienda Ospedaliera "S.Gerardo"
Recruiting
Monza, Italy
Contact: Monia Carpenedo
Principal Investigator: Monia Carpenedo
Ematologia - Ospedale San Carlo
Recruiting
Potenza, Italy
Contact: Angela Amendola
Principal Investigator: Angela Amendola
Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova
Recruiting
Reggio Emilia, Italy
Contact: Elena Rivolti
Principal Investigator: Elena Rivolti
Università Cattolica del Sacro Cuore - Policlinico A. Gemelli
Recruiting
Roma, Italy
Contact: Valerio De Stefano
Principal Investigator: Valerio De Stefano
Sub-Investigator: Elena Rossi
U.O.C. Ematologia - Ospedale S. Eugenio
Recruiting
Rome, Italy
Contact: Laura Scaramucci
Principal Investigator: Laura Scaramucci
Sub-Investigator: Pasquale Niscola
Università degli studi "Sapienza" di Roma
Recruiting
Rome, Italy
Contact: Maria Gabriella Mazzucconi
Ematologia - Dipartimento di Medicina Clinica e Sperimentale
Recruiting
Sassari, Italy
Contact: Claudio Fozza
Principal Investigator: Claudio Fozza Collapse << |
| NCT01762761 | Purpura, Thrombocytopenic, Idi... more >>opathic and Hepatitis C Collapse << | Phase 3 | Active, not recruiting | November 15, 2018 | China, Fujian
... more >> Novartis Investigative Site
Fuzhou, Fujian, China, 350001
China, Guangdong
Novartis Investigative Site
Guangzhou, Guangdong, China, 510080
Novartis Investigative Site
Guangzhou, Guangdong, China, 510515
Novartis Investigative Site
Zhongshan, Guangdong, China, 528403
China, Hunan
Novartis Investigative Site
Changsha, Hunan, China, 410013
China, Jiangsu
Novartis Investigative Site
Nanjing, Jiangsu, China, 210029
China, Jiangxi
Novartis Investigative Site
Nanchang, Jiangxi, China, 330006
China, Shandong
Novartis Investigative Site
Jianan, Shandong, China, 250012
China, Zhejiang
Novartis Investigative Site
Hangzhou, Zhejiang, China, 310003
China
Novartis Investigative Site
Beijing, China, 100034
Novartis Investigative Site
Beijing, China, 100044
Novartis Investigative Site
Beijing, China, 100083
Novartis Investigative Site
Beijing, China, 100730
Novartis Investigative Site
Chengdu, China, 610041
Novartis Investigative Site
Jiang Su Province, China, 215006
Novartis Investigative Site
Shanghai, China, 200025
Novartis Investigative Site
Shanghai, China
Novartis Investigative Site
Tianjin, China, 300020 Collapse << |
| NCT02335268 | Myelodysplastic Syndromes | Phase 2 | Recruiting | September 2020 | Germany
... more >> MVZ Onkologischer Schwerpunkt am Oskar-Helene-Heim
Active, not recruiting
Berlin, Germany
Vivantes Klinikum am Urban / Hämatologie Onkologie
Active, not recruiting
Berlin, Germany
Klinikum Chemnitz gGmbH / Klinik für Innere Medizin III
Recruiting
Chemnitz, Germany, 09116
Contact: Mathias Hänel, PD
Universitätsklinikum Dresden / Medizinische Klinik I
Recruiting
Dresden, Germany, 01307
Contact: Uwe Platzbecker, Prof.
Marienhospital Düsseldorf GmbH / Innere Medizin u. Hämatologie
Recruiting
Düsseldorf, Germany
Contact: Aristoteles Giagounidis, PD
Universitätsklinikum Halle (Saale) / Klinik für Innere Medizin IV
Recruiting
Halle, Germany, 06120
Contact: Haifa Kathrin Al-Ali, PD
Universitätsklinikum Hamburg-Eppendorf /Onkologisches Zentrum
Active, not recruiting
Hamburg, Germany, 20246
Asklepios Kliniken St. Georg / Hämatologie, Onkologie
Withdrawn
Hamburg, Germany
Medizinische Hochschule Hannover / Hämatologie u. Onkologie
Recruiting
Hannover, Germany
Contact: Michael Heuser, PD
Universitätsklinikum Mannheim / Klinik III / Hämatologie, Onkologie
Recruiting
Mannheim, Germany
Contact: Georgia Metzgeroth, Prof.
Gemeinschaftspraxis Hämatologie/Onkologie
Withdrawn
München, Germany
Klinikum Rechts der Isar, Tumortherapiezentrum
Recruiting
München, Germany
Contact: Katharina Götze, PD
MVZ für Blut u. Krebserkrankungen
Active, not recruiting
Potsdam, Germany
Universitätsklinikum Ulm / Klinik Innere Medizin III
Recruiting
Ulm, Germany
Contact: Richard Schlenk, Prof.
Onkologische Gemeinschaftspraxis
Active, not recruiting
Weilheim, Germany
Rems-Murr-Kliniken Winnenden / Hämatologie, Onkologie
Recruiting
Winnenden, Germany
Contact: Stefani Parmentier, Dr. Collapse << |
| NCT01762761 | - | - | Active, not recruiting | - | - |
| NCT01520909 | Idiopathic Thrombocytopenic Pu... more >>rpura Collapse << | Phase 3 | Completed | - | - |
| NCT01520909 | - | - | Completed | - | - |
| NCT02760251 | Immune Thrombocytopenia | Phase 4 | Recruiting | April 2020 | Switzerland
... more >> Liestal Cantonal Hospital
Recruiting
Liestal, Basel-Land, Switzerland
Contact: Geneviève Favre, Dr.med
Lucerne Cantonal Hospital
Recruiting
Lucerne, Lucern, Switzerland
Contact: Axel Rüfer, Dr. med
Aarau Cantonal Hospital
Recruiting
Aarau, Switzerland
Contact: Nathan Cantoni, Dr. med
University Hospital Basel
Recruiting
Basel, Switzerland, 4000
Contact: Jakob Passweg, Prof.Dr.med.
University Hospital Bern
Not yet recruiting
Bern, Switzerland
Contact: Alicia Rovo, Dr.med Collapse << |
| NCT00922883 | Anemia, Aplastic
... more >> Anemia, Hypoplastic
Thrombocytopenia Collapse << | Phase 2 | Active, not recruiting | August 31, 2018 | United States, Maryland
... more >>
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892 Collapse << |
| NCT01727999 | - | - | Completed | - | United States, California
... more >>
Stanford University
Stanford, California, United States, 94305
United States, New York
Weill Medical College, Cornell University
New York, New York, United States, 10065 Collapse << |
| NCT00102726 | Thrombocytopaenia | Phase 2 | Completed | - | - |
| NCT00922883 | - | - | Active, not recruiting | - | - |
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
